Loading...

SYNGENE Syngene International Ltd Major expansion or diversification plans Announcement

Syng

SYNG

Syngene International Ltd

(SYNGENE)

2025 Announcement

Analyst / Investor Meet

One to One Meeting

Analyst meeting intimation

Analyst / Investor Meeting

Analyst meeting

Analyst/Institutional Inves...

Analyst / Investor Meet

Meeting Reschedule

Analyst/Institutional Meeting

Analyst/Institutional Inves...

One-to-One Meeting

Analyst Meeting

One-to-One Meeting

Analyst meeting

Schedule Intimation

Analyst Meeting

Analyst Meet Transcript

Financial Results Published

Earnings Call Recording

Investor Presentation

Board Meeting Outcome

Q2 FY26 Results

Q2 Financial Results

Tax Litigation Update

Investor Call Announcement

Management Change

Shareholder Communication

100-Day Campaign

Compliance Certificate

Tax Litigation Update

Investor Meet Announced

Investor Presentation

Investor Meeting

Investor Meeting Postponed

Analyst Meeting

Management Change

Meeting Cancellation

Investor Meeting

Investor Meeting

Investor Meeting

Performance Share Units

Investor Meeting

Investor Meet Scheduled

Earnings Call Update

Financial Results Published

Investor Presentation

Management Change

Q1 Revenue Growth

Management Change

Investor Conference Call

Regulatory Compliance

Performance Share Units

AGM Announcement

Annual General Meeting

Investor Meeting

Investor Meeting

Investor Meeting

USFDA Inspection Update

Management Resignation

Investor Meeting

Analyst Meeting

FDA Inspection Outcome

Analyst Meeting

Analyst Meeting

Management Change

Meeting Cancellation

Investor Meetings

Investor Meet Scheduled

Postal Ballot Notice

Investor Meeting

Annual Compliance Report

Meeting Cancellation

Share Transfer Notice

Meeting Cancelled

Investor Meeting

Investor Meet Scheduled

Investor Meeting

Analyst Meeting

Investor Meeting

Earnings Call Transcript

Investor Meeting

Earnings Call Audio

Financial Results Published

Tax Appeal Filed

Appointment of Auditors

Share Allotment

Management Changes

Q4 FY25 Results

Tax Appeal Filed

Tax Appeal Filed

Compliance Certificate

Performance Share Grant

New CEO Appointment

Tax Litigation Update

Unclaimed Dividends Reminder

Income Tax Order

Tax Litigation Update

Tax Order Disclosure

Income Tax Order

Stake Acquisition

Income Tax Order

Tax Litigation Update

Income Tax Order

Facility Acquisition

Investor Meeting

Investor Presentation

Investment Announcement

US Facility Acquisition

Penalty Dropped

Tax Demand Reduction

FDA Inspection Update

Tax Relief Order

Meetings Canceled

Leadership Changes

Leadership Change

Leadership Changes

Analyst Meetings

Performance Share Units

Tax Settlement Update

Earnings Call Transcript

Tax Settlement Update

Financial Results Published

Earnings Call Audio

Management Changes

Investor Presentation

Q3 Financial Results

Conference Call Update

Investor Conference Call

Tax Settlement Update

Compliance Certificate

Trust Deed Amendment

Tax Demand Update

Investor Meeting Scheduled

Investor Meeting

Investor Meeting

Tax Demand Update

Analyst Meeting

Analyst Meeting

Investor Meeting Scheduled

Executive Resignation

PSU Grant Announcement

Investor Meeting

Analyst Meeting

Analyst Meeting

Investor Meeting

Analyst Meeting Scheduled

Investor Meeting

Analyst Meeting

Investor Meeting Scheduled

Earnings Call Transcript

Earnings Call Update

Financial Results Published

Investor Presentation

Quarterly Results

Management Change

Internal Auditor Change

Tax Refund Update

Tax Refund Dispute

Investor Conference Call

Dematerialization Certificate

Performance Share Units

Tax Refund Notice

Investor Meeting

Investor Meeting

Analyst Meeting Scheduled

Analyst Meeting Scheduled

Analyst Meeting

Analyst Meeting

Analyst Meeting

Investor Meeting Scheduled

Investor Meeting

Investor Meeting Scheduled

Analyst Meeting

Investor Meeting

Investor Meeting

Investor Meeting

Management Change

Stock Units Vested

Income Tax Refund Order

Meeting Intimation

Earnings Call Transcript

Financial Results Publication

Investor Presentation

Financial Results Announcement

Appointment Of Internal Aud...

Conference Call Announcement

Certificate Submission

Newspaper Publication

Publication of AGM Details

Insurance Claim Disbursement

Meeting Intimation

Meeting Intimation

Meeting Intimation

Meeting Schedule Intimation

Appointment of Director

Interim Disbursements

Equity shares transfer to I...

Meeting Intimation

Meeting Intimation

Analyst Meeting

Meeting Announcement

Publication Notice

Meeting with Analyst/Investor

Meeting with ENAM Capital

Compliance Filing

Meeting Intimation

Earnings Call Transcript

Regulation Disclosure

Financial Results Published

Earnings Report

Tax Appeal Submission

Compliance Certificate Subm...

Certificate Submission

Compliance Certificate Subm...

Conference Call Invitation

Income Tax Assessment Order...

Income Tax Department Orders

Appointment of Director

Meeting Intimation

Meeting Intimation

Meeting Intimation

Meeting Intimation

Meeting Rescheduled

Rescheduled Meeting

Meeting Schedule

Meeting Cancellation

Cancellation of Meetings

Meeting with Analyst/Instit...

Meeting Cancellation

Meetings Schedule

Meeting Schedule

Cancellation of Meetings

Meeting with Analyst/Investor

Meeting with Analyst/Investor

Meeting with Analyst/Investor

Meeting Schedule

Meeting with Analyst/Investor

Investor Conferences

Resignation of Dr. Mahesh B...

Meeting with Investor

Meeting with Analyst/Instit...

Meeting with Fidelity Inter...

Earnings Call Transcript Re...

Financial Results Publication

Investor Presentation

Financial Results

Appointment of Director

Conference Call for Analyst...

Penalty Proceedings Dropped

Reminder Letter/Email To Sh...

Certificate under Reg. 74 (...

Penalty Imposed

Acquisition Update

Meeting with Analyst/Instit...

Meeting with Analyst/Instit...

Refund Adjustment

Meeting with DSP Mutual Fund

Meeting with Analyst/Investor

Acquisition of Biologics Ma...

Investor Meeting

Penalty Imposed

Meeting with Analyst/Instit...

Meeting with Investor

Meeting with Analyst/Investor

Meeting with Analyst/Instit...

Trust Deed Amendment

Meeting with Analyst/Instit...

Resignation of Senior Manag...

Resignation of Dr. Carl Dec...

Meeting Announcement

Meeting Schedule

Resignation of Director

Transcript Availability

Earnings Call Audio Recording

Investor Presentation

Financial Results

Retirement of Senior Manage...

Conference Call

Certificate of SEBI Regulat...

Meeting with Analyst/Investor

Meeting Rescheduled

Meeting with Monarch AIF

Trust Deed Amendment

Meeting with Analyst/Investor

Meeting Schedule

Meeting Schedule

Analyst/Investor Meet

Schedule of Investor Meetings

Analyst Meeting

Meeting with Analyst/Instit...

Financial Statements

Financial Statements

Financial Statements

Conference Call

Newspaper Publication

Asset Acquisitions

Financial Statements

Dividend announcement

Analyst Meet - Intimation

Meeting with Analyst/Instit...

Analyst/Investor Meet - Int...

Analyst / Investor Meet - I...

Analyst/Investor Meet

Analyst/Investor Meet

Meeting Schedule

Meeting Schedule

Meeting Schedule

Analyst/Investor Meet

Meeting Intimation

Analyst / Investor Meet - I...

Meeting Schedule

External Links:

Data:

Syngene International Limited has acquired its first biologics manufacturing facility in the US to enhance its global capabilities, with increased production capacity of 50,000L for large molecules as of March 10, 2025.

AI Assistant

Syngene International Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.